The Australian Proteomics Computational Facility (APCF)
Funder
National Health and Medical Research Council
Funding Amount
$2,509,000.00
Summary
In recent years, Australia has invested in the equipment capable of identifying proteins important in health and medicine. This sophisticated equipment requires high capacity computing support. The Australian Proteomics Computational Facility will establish a single advanced computing cluster accessible to scientists at proteomics centres all over the country. This integrated approach to proteomics computing and the sharing of databases will put Australia at the forefront of the world�s efforts ....In recent years, Australia has invested in the equipment capable of identifying proteins important in health and medicine. This sophisticated equipment requires high capacity computing support. The Australian Proteomics Computational Facility will establish a single advanced computing cluster accessible to scientists at proteomics centres all over the country. This integrated approach to proteomics computing and the sharing of databases will put Australia at the forefront of the world�s efforts to identify the proteins associated with the early detection of our major diseasesRead moreRead less
Australasian Leukaemia Lymphoma Group (ALLG) National Leukaemia And Lymphoma Tissue Bank (NLLTB)
Funder
National Health and Medical Research Council
Funding Amount
$2,106,750.00
Summary
Recent advances in knowledge about how cancer differ from normal cells, why some people are susceptible to cancer, and how new treatments can target cancer have all occurred through research on cancer cells from patients. To benefit patients with cancers of the blood and the immune system, we established a National Leukaemia and Lymphoma Tissue Bank in 2002. It is proposed to dramatically expand its size, add relevant clinical data, and streamline access and utility for Australian researchers. U ....Recent advances in knowledge about how cancer differ from normal cells, why some people are susceptible to cancer, and how new treatments can target cancer have all occurred through research on cancer cells from patients. To benefit patients with cancers of the blood and the immune system, we established a National Leukaemia and Lymphoma Tissue Bank in 2002. It is proposed to dramatically expand its size, add relevant clinical data, and streamline access and utility for Australian researchers. Ultimately, this will lead to better treatment and prevention of blood cancers.Read moreRead less